437 related articles for article (PubMed ID: 22002799)
1. Adjuvant radiotherapy in the treatment of invasive intraductal papillary mucinous neoplasm of the pancreas: an analysis of the surveillance, epidemiology, and end results registry.
Worni M; Akushevich I; Gloor B; Scarborough J; Chino JP; Jacobs DO; Hahn SM; Clary BM; Pietrobon R; Shah A
Ann Surg Oncol; 2012 Apr; 19(4):1316-23. PubMed ID: 22002799
[TBL] [Abstract][Full Text] [Related]
2. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
[TBL] [Abstract][Full Text] [Related]
3. Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American Joint Committee on Cancer Stage.
Waters JA; Schnelldorfer T; Aguilar-Saavedra JR; Chen JH; Yiannoutsos CT; Lillemoe KD; Farnell MB; Sarr MG; Schmidt CM
J Am Coll Surg; 2011 Aug; 213(2):275-83. PubMed ID: 21601488
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).
McMillan MT; Lewis RS; Drebin JA; Teitelbaum UR; Lee MK; Roses RE; Fraker DL; Vollmer CM
Cancer; 2016 Feb; 122(4):521-33. PubMed ID: 26587698
[TBL] [Abstract][Full Text] [Related]
5. Clinical results of extended lymphadenectomy and intraoperative radiotherapy for pancreatic adenocarcinoma.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Tanizawa Y
Hepatogastroenterology; 2007 Mar; 54(74):564-9. PubMed ID: 17523323
[TBL] [Abstract][Full Text] [Related]
6. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.
Ceppa EP; Roch AM; Cioffi JL; Sharma N; Easler JJ; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
Surgery; 2015 Oct; 158(4):937-44; discussion 944-5. PubMed ID: 26173683
[TBL] [Abstract][Full Text] [Related]
7. Invasive IPMN and MCN: same organ, different outcomes?
Kargozaran H; Vu V; Ray P; Bagaria S; Steen S; Ye X; Gagandeep S
Ann Surg Oncol; 2011 Feb; 18(2):345-51. PubMed ID: 20809175
[TBL] [Abstract][Full Text] [Related]
8. A national propensity-adjusted analysis of adjuvant radiotherapy in the treatment of resected pancreatic adenocarcinoma.
McDade TP; Hill JS; Simons JP; Piperdi B; Ng SC; Zhou Z; Kadish SP; Fitzgerald TJ; Tseng JF
Cancer; 2010 Jul; 116(13):3257-66. PubMed ID: 20564625
[TBL] [Abstract][Full Text] [Related]
9. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms.
Nara S; Shimada K; Kosuge T; Kanai Y; Hiraoka N
Am J Surg Pathol; 2008 Feb; 32(2):243-55. PubMed ID: 18223327
[TBL] [Abstract][Full Text] [Related]
10. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
Ann Surg Oncol; 2007 Nov; 14(11):3174-80. PubMed ID: 17694416
[TBL] [Abstract][Full Text] [Related]
11. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakashima A; Sueda T
J Surg Oncol; 2009 Jul; 100(1):13-8. PubMed ID: 19384908
[TBL] [Abstract][Full Text] [Related]
12. Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival.
Raut CP; Cleary KR; Staerkel GA; Abbruzzese JL; Wolff RA; Lee JH; Vauthey JN; Lee JE; Pisters PW; Evans DB
Ann Surg Oncol; 2006 Apr; 13(4):582-94. PubMed ID: 16523362
[TBL] [Abstract][Full Text] [Related]
13. Invasive carcinoma derived from intraductal papillary mucinous carcinoma of the pancreas.
Nakagohri T; Konishi M; Inoue K; Tanizawa Y; Kinoshita T
Hepatogastroenterology; 2004; 51(59):1480-3. PubMed ID: 15362782
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas.
Swartz MJ; Hsu CC; Pawlik TM; Winter J; Hruban RH; Guler M; Schulick RD; Cameron JL; Laheru DA; Wolfgang CL; Herman JM
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):839-44. PubMed ID: 19647950
[TBL] [Abstract][Full Text] [Related]
15. Intraductal papillary mucinous neoplasms of the pancreas--predictors of malignancy.
Fan F; Lai EC; Xie F; Yang JM; Xu F; Kan T; Shen RX; Yang XY; Lau Wan Y; Wu MC
Hepatogastroenterology; 2010; 57(99-100):635-9. PubMed ID: 20698241
[TBL] [Abstract][Full Text] [Related]
16. Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes.
Wasif N; Bentrem DJ; Farrell JJ; Ko CY; Hines OJ; Reber HA; Tomlinson JS
Cancer; 2010 Jul; 116(14):3369-77. PubMed ID: 20564064
[TBL] [Abstract][Full Text] [Related]
17. Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: a clinicopathologic comparison with a common type of invasive ductal carcinoma.
Shimada K; Sakamoto Y; Sano T; Kosuge T; Hiraoka N
Pancreas; 2006 Apr; 32(3):281-7. PubMed ID: 16628084
[TBL] [Abstract][Full Text] [Related]
18. Long-term surgical outcome of noninvasive and minimally invasive intraductal papillary mucinous adenocarcinoma of the pancreas.
Nakagohri T; Asano T; Kenmochi T; Urashima T; Ochiai T
World J Surg; 2002 Sep; 26(9):1166-9. PubMed ID: 12045867
[TBL] [Abstract][Full Text] [Related]
19. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.
Schnelldorfer T; Sarr MG; Nagorney DM; Zhang L; Smyrk TC; Qin R; Chari ST; Farnell MB
Arch Surg; 2008 Jul; 143(7):639-46; discussion 646. PubMed ID: 18645105
[TBL] [Abstract][Full Text] [Related]
20. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors.
Hirono S; Tani M; Kawai M; Ina S; Nishioka R; Miyazawa M; Fujita Y; Uchiyama K; Yamaue H
Arch Surg; 2009 Apr; 144(4):345-9; discussion 349-50. PubMed ID: 19380648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
